newsfilter
← Latest News
Business Wire·

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David Urso,